Amylyx Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-108
-19,855
-141
0
EBITDA
-30,949
-34,266
-41,302
-37,647
EBIT
-31,057
-34,386
-41,443
-37,803
Net Income
-32,999
-34,386
-41,443
-35,907
Net Change In Cash
0
0
0
0
Free Cash Flow
-27,989
-30,392
-25,265
-39,835
Cash
226,651
225,178
58,085
59,764
Basic Shares
94,565
93,332
89,138
85,697

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$87,371
$380,786
$22,230
Gross Profit
-525
45,215
355,345
19,237
EBITDA
-144,164
-290,976
39,890
-200,854
EBIT
-144,689
-291,880
38,802
-201,341
Net Income
-144,735
-301,743
49,271
-198,375
Net Change In Cash
0
87,371
380,786
22,230
Cost of Revenue
12,930
Free Cash Flow
-123,481
-167,804
10,678
-182,397
Cash
226,651
77,391
170,201
62,526
Basic Shares
94,565
68,142
69,991
66,512

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
-$0.30
2025-09-30
-$0.37
2025-06-30
-$0.46